Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease. (2020)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2020.06.049
PubMed Identifier: 32579980
Publication URI: http://europepmc.org/abstract/MED/32579980
Type: Journal Article/Review
Volume: 81
Parent Publication: The Journal of infection
Issue: 4
ISSN: 0163-4453